BVMF/R1VT34 (BVMF/R1VT34)

Brazil Stock Exchange: BVMF/R1VT34 · BRL

R$31.4

+0.05 (+0.2%)· Recorded snapshot

Market cap	96.6B
Revenue (ttm)	15.1B
Net income (ttm)	1.2B
EPS (ttm)	R$0.40
P/E (trailing)	78.1x
P/E (forward)	28.6x
Dividend	R$0.03 (0.11%)
Volume	2
Beta	1.06

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.1B
Net income (ttm): 1.2B
EPS (ttm): R$0.40
P/E (trailing): 78.1x
P/E (forward): 28.6x
Market cap: 96.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.6

P25 n/aP50 n/aP75 n/a

Trailing P/E78.1

P25 n/aP50 n/aP75 n/a

ROE3.2

P25 n/aP50 n/aP75 n/a

ROIC4.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/R1VT34 indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-03
Employees	11,000
Employees change	0
Employees growth	0%
Enterprise value	BRL 109B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-07-05
First seen	2026-07-12
Fiscal year end	December
Founded	1937
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	BRR1VTBDR000
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2022-11-28
Last stock split type	Forward
Market cap	BRL 96.6B
Next earnings date	2026-11-03
Price	BRL 31.38
Price currency	BRL
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-27
Symbol	bvmf/R1VT34
Website	https://www.revvity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	36.43x
Average P/E ratio (3Y)	48.23x
Average P/E ratio (5Y)	38.6x
Earnings yield	1.28%
EV/Earnings	88.66x
EV/EBIT	43.96x
EV/EBITDA	21.98x
EV/FCF	37.74x
EV/Sales	7x
FCF / EV yield	2.65%
FCF yield	2.99%
Forward P/E	28.58x
Graham number	10.44995
Graham upside	-66.7%
Lynch fair value	BRL 2.00
Lynch upside	-93.64%
P/(FCF - SBC) ratio	34.98x
P/(OCF - SBC) ratio	30.94x
P/B ratio	2.58x
P/E ratio	78.09x
P/FCF ratio	33.44x
P/OCF ratio	29.74x
P/S ratio	6.41x
Price/EBITDA ratio	21.31x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.92%
EBITDA margin	30.08%
Effective tax rate	8.97%
FCF margin	18.46%
Gross margin	54.98%
Operating margin	15.92%
Pretax margin	8.96%
Profit margin	8.16%
Profit per employee	BRL 111,735
Profitable quarters	34
Profitable years	23
Revenue per employee	BRL 1.4M
ROA	2.37%
ROA (5Y)	3.43%
ROCE	4.3%
ROE	3.21%
ROE (5Y)	6.53%
ROIC	4.39%
ROIC (5Y)	5.76%
SBC / revenue	0.84%
Tax / revenue	0.8%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-11.5%
EPS growth (Q)	1.16%
EPS growth (QoQ)	27.57%
EPS growth 10Y	-0.01%
EPS growth 3Y	-31.42%
EPS growth 5Y	-27.59%
EPS growth quarters	3
EPS growth years	0
FCF growth	10.97%
FCF growth (Q)	56.67%
FCF growth (QoQ)	89.48%
FCF growth 3Y	53.87%
FCF growth 5Y	-16.56%
Gross profit growth	2.3%
Gross profit growth (Q)	6.19%
Gross profit growth 3Y	-0.71%
Gross profit growth 5Y	-9.5%
Net income growth	-16.71%
Net income growth (Q)	-3.95%
Net income growth (QoQ)	27.27%
Net income growth 3Y	-33.78%
Net income growth 5Y	-27.46%
Net income growth years	0
OCF growth	7.36%
OCF growth (Q)	42.9%
OCF growth (QoQ)	66.57%
OCF growth 10Y	7.16%
OCF growth 3Y	40.3%
OCF growth 5Y	-15.48%
Operating income growth	9.85%
Operating income growth (Q)	20.69%
Operating income growth 3Y	-3.16%
Operating income growth 5Y	-21.41%
Revenue growth	4.05%
Revenue growth (Q)	1.31%
Revenue growth (QoQ)	2.61%
Revenue growth 10Y	3.58%
Revenue growth 3Y	0.87%
Revenue growth 5Y	-7.32%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -359.7M
Depreciation and amortization	BRL 2.2B
EBIT	BRL 2.4B
EBITDA	BRL 4.5B
EPS	BRL 0.40
Financing cash flow	BRL -2.6B
Free cash flow	BRL 2.9B
Free cash flow minus SBC	BRL 2.8B
Gross profit	BRL 8.3B
Income taxes	BRL 121.1M
Investing cash flow	BRL -430.8M
Net borrowing	BRL -2.2M
Net cash flow	BRL 161.4M
Net income	BRL 1.2B
Operating cash flow minus SBC	BRL 3.1B
Operating income	BRL 2.4B
Revenue	BRL 15.1B
Stock-based compensation	BRL 126.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.54
Book value per share	BRL 335.18
Debt / EBITDA	3.6
Debt / equity	0.46
Debt / FCF	5.99
Goodwill	BRL 35.5B
Interest coverage	4.93
Long-term assets	BRL 50B
Long-term liabilities	BRL 18.1B
Net cash (debt)	BRL -12B
Net cash / market cap	-12.42%
Net debt / EBITDA	2.65
Net debt / equity	0.32
Net debt / FCF	4.15
Piotroski F-Score	6
Property, plant and equipment	BRL 3.3B
Shareholders' equity	BRL 37.4B
Tangible book value	BRL -8.3B
Tangible book value per share	BRL -74.33
Total assets	BRL 62.3B
Total cash	BRL 5.3B
Total debt	BRL 17.3B
Total liabilities	BRL 24.9B
WACC	8.96%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.24
Current assets	BRL 12.3B
Current liabilities	BRL 6.9B
Current ratio	1.8
Inventory turnover	3.42
Net working capital	BRL 3B
Quick ratio	1.36
Working capital	BRL 5.3B
Working capital turnover	11.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	6.21%
Dividend growth	-7.98%
Dividend growth (3Y)	0.62%
Dividend growth (5Y)	-0.88%
Dividend growth years	2
Dividend payment date	2026-11-19
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.03
Dividend yield	0.11%
Ex-dividend date	2026-10-22
Last dividend	BRL 0.01
Payout ratio	13.36%
Shareholder yield	6.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 20.12
1D price change	0.16%
1M price change	52.33%
1M total return	52.38%
1W price change	13.7%
1W total return	13.73%
1Y price change	91.81%
1Y return CAGR	92.33%
1Y total return	92.24%
20-day SMA	BRL 20.59
200-day SMA	BRL 21.35
3M price change	56.9%
3M total return	56.95%
3Y price change	76.29%
3Y return CAGR	21.01%
3Y total return	77.23%
50-day SMA	BRL 19.36
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 31.38
52-week high date	2026-10-27
52-week low	BRL 14.91
52-week low date	2026-04-23
5Y price change	-5.01%
5Y return CAGR	-0.86%
5Y total return	-4.2%
6M price change	102.32%
6M total return	102.48%
All-time high	BRL 39.55
All-time high date	2021-12-28
All-time low	BRL 11.96
All-time low date	2020-03-12
Average true range (ATR)	BRL 1.37
Average volume	21.6
Beta (5Y)	1.06
Change from 52-week high	0%
Change from 52-week low	110.46%
Change from all-time high	-20.65%
Change from all-time low	162.44%
Change from open	0%
Day's gap	0.16%
Dollar volume	BRL 62.76
High price	BRL 31.38
Low price	BRL 31.38
Monthly RSI	67.95
Open price	BRL 31.38
Previous close	BRL 31.33
Price vs 150-day SMA	55.99%
Price vs 20-day SMA	52.37%
Price vs 200-day SMA	47%
Price vs 50-day SMA	62.11%
Relative volume	0.09
RSI	80.11
Sharpe ratio	0.74
Sortino ratio	1.31
Volume	2
Weekly RSI	64.73
YTD price change	67.81%
YTD total return	68.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	102.5M
Shares change (QoQ)	-0.22%
Shares change (YoY)	-6.21%
Shares held by insiders	0.41%
Shares held by institutions	95.55%
Short ratio	3.5 days

Deeper analysis on BVMF/R1VT34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/R1VT34 report

Is a complete BVMF/R1VT34 research report available?

No complete published report is available for bvmf/R1VT34 (BVMF/R1VT34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/R1VT34 (BVMF/R1VT34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/R1VT34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/R1VT34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/R1VT34

Frequently asked questions